Dr. Chaitanya "Chait" Iragavarapu, MD, specializes in hematology, oncology, and blood/marrow transplantation. He currently serves as an Assistant Professor of Medicine at the University of Kentucky. He obtained his medical school diploma from Stanley Medical College prior to residency in internal medicine, and fellowships in hematology, oncology, and blood/marrow transplantation. His research focuses on hematologic malignancies, cellular therapies, and precision oncology with interest in outcomes research and novel therapeutics. He also serves as a site principal investigator for multiple clinical trials focused on management of lymphoma and cellular therapies. Dr. Chait provides outpatient and inpatient care for patients with hematologic malignancies, including stem cell transplants and immune therapies, in the Kentucky community. His administrative responsibilities currently include the medical directorship of the Immune Effector Cell Therapy Program and the BMT Quality Assurance/Improvement Committee, focusing on program safety, compliance, and quality standards.